Jim Simons's position in Xeris Biopharma Holdings is currently worth $2.43 Million. That's 0.00% of their equity portfolio (1744th largest holding). The first Xeris Biopharma Holdings trade was made in Q2 2019. Since then Jim Simons bought shares nine more times and sold shares on eight occasions. The investor's estimated purchase price is $4.82 Million, resulting in a loss of 50%.